WarrenDavidShlomchikMD
Oncology • Pittsburgh, PAHematologic Oncology
Associate Professor, Comprehensive Cancer Center, Yale University School of Medicine
Dr. Shlomchik is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5115 Centre Avenue
BST E1552
Pittsburgh, PA 15232- Is this information wrong?
Education & Training
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 1993 - 1997
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1989 - 1992
Perelman School of Medicine at the University of PennsylvaniaClass of 1989
Certifications & Licensure
PA State Medical License 1993 - 2024
CT State Medical License 2000 - 2015
NY State Medical License 1991 - 1994
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2008
Clinical Trials
- Selective Depletion of CD45RA+T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD Start of enrollment: 2009 Dec 17
- Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD Start of enrollment: 2015 Feb 03
- Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS) Start of enrollment: 2019 Nov 19
Publications & Presentations
PubMed
- Natalizumab for GVHD: too little or too late?Kevin Quann, Faruk Sacirbegovic, Warren D Shlomchik> ;Blood Advances. 2023 Sep 12
- 4 citationsTissue-resident memory T cell maintenance during antigen persistence requires both cognate antigen and interleukin-15.Roger Tieu, Qiang Zeng, Daqiang Zhao, Gang Zhang, Neda Feizi, Priyanka Manandhar, Amanda L Williams, Benjamin Popp, Michelle A Wood-Trageser, Anthony J Demetris, J Yun...> ;Science Immunology. 2023 Apr 21
- 10 citationsGraft-versus-host disease is locally maintained in target tissues by resident progenitor-like T cells.Faruk Sacirbegovic, Matthias Günther, Alessandro Greco, Daqiang Zhao, Xi Wang, Meng Zhou, Sarah Rosenberger, Martin H Oberbarnscheidt, Werner Held, Dhanpat Jain, Thoma...> ;Immunity. 2023 Feb 14
- Join now to see all
Press Mentions
Novel Transplant Approach Improves the Odds for Leukemia PatientsJanuary 10th, 2022
Grant Support
- Leukemia Stem Cells: Essential Targets For GVL And Mediators Of Gvl-ResistanceNational Cancer Institute2009–2012
- Role Of Tissue Antigen Presenting Cells In GVHDNational Heart, Lung, And Blood Institute2011
- Dendritic Cell Subsets And Paths Of Maturation In GVHDNational Institute Of Allergy And Infectious Diseases2010
- Dendritic Cell Subsets And Paths Of Maturation In Graft-Vs.-Host Disease (GVHD)National Heart, Lung, And Blood Institute2007–2010
- Dendritic Cell Subsets And Paths Of Maturation In GVHDNational Institute Of Allergy And Infectious Diseases2006–2009
- Graft Versus Leukemia Against Murine Chronic Phase &Blast Crisis CMLNational Cancer Institute2007
- Dendritic Cell Subsets And Paths Of Maturation In GVHDNational Heart, Lung, And Blood Institute2006
- GVL Against Murine Chronic Phase And Blast Crisis CMLNational Cancer Institute2003–2006
- Novel Immunotoxins For Depletion Of Dendritic CellsNational Heart, Lung, And Blood Institute2005
- Alloimmunity To CML In A Novel Murine ModelNational Heart, Lung, And Blood Institute1999–2002
- Pathogenic Mechanisms Of GVD In Murine ModelNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2000
- Alloimmunity To CML In A Novel Murine ModelNational Heart, Lung, And Blood Institute1998
Hospital Affiliations
UPMC Presbyterian ShadysidePittsburgh, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
